Hypertension in the ESRD patient: Pathophysiology, therapy, outcomes, and future directions

Keyphrases

• American Society 25%
• Cardiovascular Disease 25%
• Cardiovascular Risk 25%
• Chronic Kidney Disease 50%
• Clinical Practice 50%
• Clinical Research 25%
• Clinical Treatment 25%
• Dialysis Patients 25%
• End-stage Renal Disease 25%
• End-stage Renal Disease Patients 100%
• Evidence-based Clinical Practice Guideline 50%
• Health Care Financing Administration 75%
• Hypertension 100%
• Hypertension Management 25%
• Hypertensive 25%
• Leading Causes of Death 25%
• Left Ventricular Dysfunction 25%
• National Kidney Foundation 25%
• Nephrologists 25%
• Nephrology 25%
• Pathophysiology 100%
• Patient Demographics 50%
• Premature Atherosclerosis 25%
• Renal Dialysis 25%
• Renal Disease 25%
• Renal Replacement Therapy 25%
• Renal Transplant Recipients 25%
• Therapeutic Area 25%
• Therapeutic Guidelines 25%
• Therapy Outcome 100%
• Treatment Algorithm 25%
• Valuable Resources 25%
• Vascular Disease 25%

Medicine and Dentistry

• Atherosclerosis 20%
• Cardiovascular Disease 20%
• Cardiovascular Disease Risk Factor 20%
• Chronic Kidney Disease 40%
• End Stage Renal Disease 100%
• Health Care Financing 60%
• Heart Left Ventricle Failure 20%
• Hemodialysis 20%
• Hyperlipidemia 20%
• Kidney Graft 20%
• Nephrologist 20%
• Nephrology 20%
• Nephropathy 20%
• Pathophysiology 100%
• Patient Population 40%
• Prematurity 20%
• Renal Replacement Therapy 20%
• Vascular Disease 20%